• Contact Us
  • Glossary
  • Useful Websites
  • Download Library
  • Alert Service
  • About Vernalis
  • R & Centre
  • Business Development
  • Investor Centre
  • News Centre
  •  
  • Home

News Centre

Home / News Centre / Latest Releases / 2004
PrintEmailBookmark
  • Latest Releases
  • Regulatory Announcements
  • Vernalis Group Archive
  • British Biotech Archive
  • RiboTargets Archive
  • Media Contacts

Latest Releases

  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003

If you would like to be alerted when a press release is added to this site, please register with the Alert Service.

Select a Month:
Select a Year:
Search for:
Run your search


Date Title
23/11/2004 Recruitment under way in confirmatory Frova® efficacy study for prophylaxis of menstrually related migraine
18/11/2004 John Slater joins Vernalis as General Counsel
29/09/2004 Vernalis announces Italian launch of frovatriptan
17/09/2004 Completion of collaboration with Novartis
17/09/2004 Vernalis plc: interim results for the six months ended 30 June 2004
24/08/2004 Drawdown of loan from Endo Inc, and repayment of amounts due to Elan Ltd
18/08/2004 Completion of the licensing of Frova™ to Endo
09/08/2004 Vernalis extends cancer research collaboration with Novartis Institutes for BioMedical Research
15/07/2004 Vernalis plc and Endo Pharmaceuticals Holdings Inc. announce North American licence agreement and co-promotion option for Frova™
24/06/2004 Vernalis and Biogen Idec to collaborate on research for Parkinson’s disease
Page 1  2    >>
  • Privacy
  • Legal
  • Site Map